Holen Sie sich die Stockscreener-App
96.82
1.51%
-1.48
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt CLX?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$98.30
Offen:
$98.9
24-Stunden-Volumen:
1.95M
Relative Volume:
0.71
Marktkapitalisierung:
$11.71B
Einnahmen:
$6.76B
Nettoeinkommen (Verlust:
$770.00M
KGV:
15.73
EPS:
6.1566
Netto-Cashflow:
$380.00M
1W Leistung:
+2.85%
1M Leistung:
+8.65%
6M Leistung:
-6.91%
1J Leistung:
-23.93%
1-Tages-Spanne:
$96.60
$99.23
1-Wochen-Bereich:
$92.78
$100.73
52-Wochen-Spanne:
$84.70
$132.00
Clorox Co Stock (CLX) Company Profile
Firmenname
Clorox Co
Sektor
Telefon
(510) 271-7000
Adresse
THE CLOROX COMPANY, OAKLAND, CA
Compare CLX vs PG, UL, CL, KVUE, KMB
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CLX
Clorox Co
|
96.82 | 11.89B | 6.76B | 770.00M | 380.00M | 6.1566 |
PG
Procter Gamble Co
|
149.61 | 345.42B | 86.72B | 16.69B | 15.03B | 6.8375 |
UL
Unilever Plc Adr
|
58.92 | 126.29B | 56.67B | 6.96B | 7.39B | 3.1265 |
CL
Colgate Palmolive Co
|
89.45 | 71.53B | 20.80B | 2.22B | 3.77B | 2.5772 |
KVUE
Kenvue Inc
|
18.14 | 34.69B | 15.29B | 1.62B | 1.82B | 0.8433 |
KMB
Kimberly Clark Corp
|
102.29 | 33.71B | 16.56B | 1.75B | 1.84B | 6.36 |
Clorox Co Stock (CLX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-04-17 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2026-02-11 | Hochstufung | BNP Paribas Exane | Underperform → Neutral |
| 2025-10-01 | Bestätigt | Barclays | Underweight |
| 2025-01-07 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
| 2024-11-06 | Hochstufung | TD Cowen | Sell → Hold |
| 2024-10-01 | Hochstufung | Jefferies | Hold → Buy |
| 2024-07-23 | Eingeleitet | TD Cowen | Sell |
| 2024-06-24 | Eingeleitet | Exane BNP Paribas | Underperform |
| 2024-04-02 | Herabstufung | Citigroup | Buy → Neutral |
| 2024-03-26 | Hochstufung | Jefferies | Underperform → Hold |
| 2024-03-01 | Fortgesetzt | Goldman | Sell |
| 2024-02-05 | Herabstufung | DA Davidson | Buy → Neutral |
| 2023-12-15 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2023-11-22 | Hochstufung | JP Morgan | Underweight → Neutral |
| 2023-11-13 | Eingeleitet | Jefferies | Underperform |
| 2023-11-06 | Hochstufung | UBS | Sell → Neutral |
| 2023-11-02 | Hochstufung | Citigroup | Neutral → Buy |
| 2023-10-12 | Hochstufung | Bernstein | Underperform → Mkt Perform |
| 2023-10-05 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2023-10-02 | Hochstufung | DA Davidson | Neutral → Buy |
| 2023-09-22 | Eingeleitet | HSBC Securities | Hold |
| 2023-08-03 | Hochstufung | Atlantic Equities | Underweight → Neutral |
| 2023-02-17 | Eingeleitet | Citigroup | Neutral |
| 2022-10-18 | Eingeleitet | Evercore ISI | Underperform |
| 2022-10-17 | Hochstufung | Morgan Stanley | Underweight → Equal-Weight |
| 2022-09-14 | Fortgesetzt | BofA Securities | Underperform |
| 2022-07-13 | Eingeleitet | Raymond James | Outperform |
| 2022-02-04 | Herabstufung | Atlantic Equities | Neutral → Underweight |
| 2022-02-04 | Bestätigt | Deutsche Bank | Hold |
| 2022-02-04 | Bestätigt | JP Morgan | Underweight |
| 2022-02-04 | Bestätigt | Morgan Stanley | Underweight |
| 2022-02-04 | Bestätigt | UBS | Sell |
| 2022-02-04 | Bestätigt | Wells Fargo | Underweight |
| 2022-02-02 | Herabstufung | Bernstein | Mkt Perform → Underperform |
| 2022-01-26 | Herabstufung | Credit Suisse | Neutral → Underperform |
| 2021-11-02 | Bestätigt | DA Davidson | Neutral |
| 2021-11-02 | Bestätigt | Deutsche Bank | Hold |
| 2021-11-02 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2021-11-02 | Bestätigt | Wells Fargo | Underweight |
| 2021-09-03 | Herabstufung | Argus | Buy → Hold |
| 2021-08-04 | Herabstufung | Atlantic Equities | Overweight → Neutral |
| 2021-08-04 | Bestätigt | Citigroup | Buy |
| 2021-08-04 | Bestätigt | Credit Suisse | Neutral |
| 2021-08-04 | Bestätigt | Deutsche Bank | Hold |
| 2021-08-04 | Bestätigt | Morgan Stanley | Underweight |
| 2021-08-04 | Bestätigt | RBC Capital Mkts | Sector Perform |
| 2021-08-04 | Bestätigt | UBS | Sell |
| 2021-08-04 | Bestätigt | Wells Fargo | Underweight |
| 2021-06-24 | Eingeleitet | UBS | Sell |
| 2021-05-03 | Herabstufung | Wells Fargo | Overweight → Underweight |
| 2021-03-18 | Herabstufung | DA Davidson | Buy → Neutral |
| 2021-02-19 | Hochstufung | Atlantic Equities | Neutral → Overweight |
| 2021-01-20 | Eingeleitet | Bernstein | Mkt Perform |
| 2020-12-14 | Hochstufung | Citigroup | Neutral → Buy |
| 2020-12-08 | Eingeleitet | Wells Fargo | Overweight |
| 2020-10-16 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2020-06-30 | Eingeleitet | DA Davidson | Buy |
| 2020-03-19 | Herabstufung | Credit Suisse | Outperform → Neutral |
| 2020-03-16 | Hochstufung | JP Morgan | Underweight → Overweight |
| 2020-03-09 | Hochstufung | Argus | Hold → Buy |
| 2019-10-03 | Bestätigt | BofA/Merrill | Neutral |
| 2019-09-23 | Herabstufung | Barclays | Equal Weight → Underweight |
| 2019-05-20 | Herabstufung | Argus | Buy → Hold |
| 2019-05-02 | Bestätigt | BofA/Merrill | Neutral |
| 2019-05-02 | Hochstufung | Deutsche Bank | Sell → Hold |
| 2019-04-08 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2019-03-07 | Eingeleitet | Credit Suisse | Outperform |
| 2018-12-06 | Bestätigt | BofA/Merrill | Neutral |
| 2018-09-25 | Hochstufung | Argus | Hold → Buy |
| 2018-07-18 | Herabstufung | Goldman | Neutral → Sell |
| 2018-04-19 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2018-02-08 | Herabstufung | Argus | Buy → Hold |
| 2018-01-04 | Hochstufung | BofA/Merrill | Underperform → Neutral |
Alle ansehen
Clorox Co Aktie (CLX) Neueste Nachrichten
UBS reiterates Clorox stock neutral rating citing near-term challenges - Investing.com
UBS reiterates Clorox stock neutral rating citing near-term challenges By Investing.com - Investing.com Canada
ICICI Prudential Asset Management Co Ltd Buys 22,100 Shares of The Clorox Company $CLX - MarketBeat
Clorox Co. Stock (US1890541097): Valuation metrics in focus after recent rebound - AD HOC NEWS
Andra AP fonden Buys 123,843 Shares of The Clorox Company $CLX - MarketBeat
Clorox Co. stock underperforms Thursday when compared to competitors - MarketWatch
Clorox (NYSE:CLX) Shares Unloaded Rep. Gilbert Ray Cisneros, Jr. - MarketBeat
Clorox Co. Stock (US1890541097): Market reacts to $2.25 billion Purell deal and rerates the consumer - AD HOC NEWS
Burt’s Bees and Food teammates bring purpose to life at Consumer Week - The Clorox Company
5 Best Dividend Stocks to Own in Case the AI Trade Ends - The Motley Fool
A Look at Clorox Co (CLX) After 3.5% Gain -- GF Value $133.91 vs Price $98.48 - GuruFocus
Clorox Co. stock outperforms competitors on strong trading day - MarketWatch
Clorox, Southern Glazer’s, SmartSKN Turn to Predictive Analytics to Sharpen Supply Chains - Consumer Goods Technology
Natixis Advisors LLC Reduces Position in The Clorox Company $CLX - MarketBeat
Clorox Co. stock (US1890541097): Cleaning giant stabilizes after cyberattack and pricing actions - AD HOC NEWS
Burt's Bees Lip Balm: Natural Lip Care Staple for Everyday Use - AD HOC NEWS
Meet Hannah Houts, Glad brand manager - The Clorox Company
CLX Stock Quote Price and Forecast - CNN
Bank of New York Mellon Corp Raises Stock Holdings in The Clorox Company $CLX - MarketBeat
Burt's Bees Lip Balm: Natural Lip Care for Everyday Use - AD HOC NEWS
CLX Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Nuance Investments LLC Has $79.33 Million Holdings in The Clorox Company $CLX - MarketBeat
CSX Corp stock (US1890541097): Susquehanna lifts target as shares trade near 52-week highs - AD HOC NEWS
The Clorox Company $CLX Shares Acquired by BNP Paribas Financial Markets - MarketBeat
Clorox prices $1.5 billion debt offering in three parts - Investing.com
Clorox Co stock (US18539C2044): shares ease while investors focus on inflation impact and sector tre - AD HOC NEWS
Consumer products giants cite rising costs, supply chain pressures from Middle East conflict - Plastics News
Clorox Co. stock underperforms Wednesday when compared to competitors - MarketWatch
Clorox Co at Deutsche Bank dbAccess Global Consumer Conference Transcript - GuruFocus
Clorox Co. stock underperforms Friday when compared to competitors - MSN
Clorox Co stock (US1890541097): new Clorox Healthcare wipes launch adds product momentum after recen - AD HOC NEWS
Clorox Healthcare Debuts Bleach-Free Wipes - Happi | Household And Personal Products Industry
Clorox Healthcare Introduces Two Breakthrough Innovations to Help Solve Infection Prevention Challenges - The Clorox Company
New Clorox healthcare wipes eliminate C. diff spores without bleach - Stock Titan
Clorox Uses Social Commerce to Test New Scents - Consumer Goods Technology
Nomura Asset Management Co. Ltd. Buys 16,852 Shares of The Clorox Company $CLX - MarketBeat
National Pension Service Acquires 11,233 Shares of The Clorox Company $CLX - MarketBeat
Clorox Co. stock outperforms competitors despite losses on the day - MarketWatch
Clorox Co stock (US18539C2044): shares steady as U.S. consumer staples name digests recent earnings - AD HOC NEWS
Clorox Co. stock (US1890541097): shares drop after CEO Linda Rendle announces departure - AD HOC NEWS
The Clorox Company $CLX Shares Sold by Pring Turner Capital Group Inc. - MarketBeat
Clorox Co. stock (US1890541097): shares steady as investors await next catalysts - AD HOC NEWS
Coldstream Capital Management Inc. Has $290,000 Stock Position in The Clorox Company $CLX - MarketBeat
Clorox Announces Leadership Transition as CEO Linda Rendle Prepares to Exit - Insider Monkey
Clorox Co. stock (US1890541097): CEO transition and outlook cut weigh on NYSE-listed shares - AD HOC NEWS
Clorox Veteran Linda Rendle To Step Down As CEO - ESM Magazine
Ilmarinen Mutual Pension Insurance Co Buys New Position in The Clorox Company $CLX - MarketBeat
Legal & General Group Plc Reduces Stake in The Clorox Company $CLX - MarketBeat
Clorox CEO to step down after revealing cancer diagnosis - Yahoo Finance
Clorox Co (CLX) Shares Fall 6.4% -- What GF Score of 75 Tells In - GuruFocus
Clorox Co stock (US18539C2044): CEO transition and valuation metrics in focus - AD HOC NEWS
Finanzdaten der Clorox Co-Aktie (CLX)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.77%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):